Comparison of laser therapy and pharmacotherapy in ulcer treatment

Comparative evaluation of LLLT versus topical application of Amlexanox + Lidocaine in the management of Recurrent aphthous ulcers- A randomised controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/021912

Enrollment

Registered

2019-11-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K120- Recurrent oral aphthae

Interventions

Intervention1: Low Level Laser Therapy: Low Level Laser Therapy(LLLT) has biomodulation and analgesic effect by stimulation of healing process, promoting immediate relief of pain. LLLT is provided wit

Eligibility

Inclusion criteria

Inclusion criteria: 1. subjects having the recurrent aphthous ulcers in the oral cavity via the criteria proposed by Natah et al. in 2004 2.subjects who are ready to give the consent and follow the schedule 3. subjects without any medical illness

Exclusion criteria

Exclusion criteria: 1. subjects currently undergoing any therapy for recurrent aphthous ulcers 2. subjects on medications like analgesics and immunosuppressants 3. pregnant or lactating mothers/subjects 4. subjects with any other lesions in the oral cavity

Design outcomes

Primary

Measure	Time frame
1. Pain perception 2. Size of ulcerTimepoint: Baseline Second day Third day One week after the therapy	—

Secondary

Measure	Time frame
Healing of aphthous ulcerTimepoint: Second day Third day One week after the therapy	—

Countries

India

Contacts

Public ContactDr Ruchi Nagpal

Sudha Rustagi college of dental sciences and research

maryacm@yahoo.co.uk9811144408

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026